138 related articles for article (PubMed ID: 34407037)
1. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
[TBL] [Abstract][Full Text] [Related]
2. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
[TBL] [Abstract][Full Text] [Related]
3. Preservative-free 0.9% sodium chloride for flushing and locking peripheral intravenous access device: a prospective controlled trial.
Wang R; Luo O; He L; Li JX; Zhang MG
J Evid Based Med; 2012 Nov; 5(4):205-8. PubMed ID: 23557500
[TBL] [Abstract][Full Text] [Related]
4. Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.
Dal Molin A; Clerico M; Baccini M; Guerretta L; Sartorello B; Rasero L
Eur J Oncol Nurs; 2015 Dec; 19(6):638-43. PubMed ID: 25933709
[TBL] [Abstract][Full Text] [Related]
5. Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely: A Systematic Review and Meta-analysis.
Clari M; Spoto M; Franceschi G; Acuto M; Tonella S; Caristia S; Buratti G; Gaboardi S; Rasero L; Campagna S; Busca E; Dal Molin A
Cancer Nurs; 2021 May-Jun 01; 44(3):205-213. PubMed ID: 32384421
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.
Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P
Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390
[TBL] [Abstract][Full Text] [Related]
7. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
[TBL] [Abstract][Full Text] [Related]
9. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
He J
J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
[TBL] [Abstract][Full Text] [Related]
10. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
11. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
[TBL] [Abstract][Full Text] [Related]
12. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
[TBL] [Abstract][Full Text] [Related]
13. The effects of heparin flush on patency of the Groshong catheter: a pilot study.
Mayo DJ; Horne MK; Summers BL; Pearson DC; Helsabeck CB
Oncol Nurs Forum; 1996 Oct; 23(9):1401-5. PubMed ID: 8899756
[TBL] [Abstract][Full Text] [Related]
14. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
[TBL] [Abstract][Full Text] [Related]
15. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
[TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
18. Varied flushing frequency and volume to prevent peripheral intravenous catheter failure: a pilot, factorial randomised controlled trial in adult medical-surgical hospital patients.
Keogh S; Flynn J; Marsh N; Mihala G; Davies K; Rickard C
Trials; 2016 Jul; 17(1):348. PubMed ID: 27456005
[TBL] [Abstract][Full Text] [Related]
19. Heparin vs Saline Infusion to Maintain Patency of Arterial Catheters in Children: A Randomized, Double-Blind, Noninferiority Trial.
Kowshik M S; Ganesamurthy K; Ramachandran B; Krupanandan R; Sadasivam K
Indian Pediatr; 2024 Feb; 61(2):132-138. PubMed ID: 38217267
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
